Selected article for: "acute kidney injury and liver disease"
Author: Armstrong-James, Darius; Koh, Mickey; Ostermann, Marlies; Cockwell, Paul
Title: Optimal management of acute kidney injury in critically ill patients with invasive fungal infections being treated with liposomal amphotericin B
  • Cord-id: 34lor0tl
  • Document date: 2020_5_12
    • ID: 34lor0tl
    Snippet: Critically ill patients are at risk of developing both acute kidney injury (AKI) and invasive fungal infections (IFIs). Prompt and efficient treatment of the IFI is essential for the survival of the patient. This article examines three distinct clinical situations where liposomal amphotericin B, a broad-spectrum antifungal agent, was successfully used in the setting of AKI. The first was Aspergillus infection in a 63-year-old man with bleeding oesophageal varices related to advanced liver diseas
    Document: Critically ill patients are at risk of developing both acute kidney injury (AKI) and invasive fungal infections (IFIs). Prompt and efficient treatment of the IFI is essential for the survival of the patient. This article examines three distinct clinical situations where liposomal amphotericin B, a broad-spectrum antifungal agent, was successfully used in the setting of AKI. The first was Aspergillus infection in a 63-year-old man with bleeding oesophageal varices related to advanced liver disease. The second was gastrointestinal mucormycosis in a 74-year-old man who developed a small bowel obstruction following an autologous stem cell transplant for mantle cell lymphoma. The third was a Fusarium infection in a 32-year-old woman on immunosuppression for a bilateral lung transplant for cystic fibrosis. In all three cases, liposomal amphotericin B was required for urgent management of the patient’s IFI. We discuss the rationale for treatment with a potentially nephrotoxic agent in this setting.

    Search related documents:
    Co phrase search for related documents
    • accurate monitoring and acute aki kidney injury: 1, 2
    • accurate monitoring and long term monitoring: 1, 2
    • acid base status and acute aki kidney injury: 1, 2
    • acid base status and liver disease: 1
    • acute aki kidney injury and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute aki kidney injury and low incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute rejection and liver disease: 1, 2, 3, 4
    • acute rejection and lung transplant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adequate organ perfusion and liver disease: 1
    • liver disease and low incidence: 1, 2, 3, 4, 5
    • liver disease and low likelihood: 1
    • liver disease and lung transplant: 1, 2, 3
    • low incidence and lung transplant: 1, 2